 |
James H. Finke, Ph.D.StaffDepartment of Immunology |
Area of general research interest:
Tumor immunity, T lymphocytes, signal transduction, oxidative stress and T-cell dysfunction in cancer
Current program:
- Development of a Th2 bias in renal cell carcinoma (RCC) patients.
- Mechanisms of apoptosis in T cells from tumor bearing patients.
- Role of gangliosides, Treg cell, and myeloid derived suppressorcells in T-cell dysfunction in RCC patients.
Investigators:
- Kaushik Biswas, Ph.D.
- Soumika Biswas, B.S.
- Sankar Ghosh, D.V.M., Ph.D.
- Saby George, M.D.
- Jennifer Smith, M.D.
- Tashi Smith-Williams
- Yuntao Li, B.A.
- Joanna Ireland, M.S.
- Patricia Rayman, M.S.
Collaborators:
- Ronald Bukowski, M.D., Experimental Therapeutics, Department of Solid Tumor Oncology, Cleveland Clinic
- Guy Chisolm, Ph.D., Department of Cell Biology, LRI, Cleveland Clinic
- Tanya Das, Ph.D., Bose Institute, Kolkata, India
- Inderbir Gill, M.D., Glickman Urological Institute, Cleveland Clinic
- Brian Rini, M.D., Department of Solid Tumor Oncology, Cleveland
- Andrew Novick, M.D., Department of Urology, Cleveland Clinic
- Eric Hsi, M.D., Department of Clinical Pathology, Cleveland Clinic
- Gaurisankar Sa, Ph.D., Bose Institute, Kolkata, India
- Walter Storkus, Ph.D., Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA
- Charles Tannenbaum, Ph.D., Department of Immunology, LRI, Cleveland Clinic
- Michael Vogelbaum, M.D., Department of Neurosurgery, Brain Tumor Institute, Cleveland Clinic
- Renliang Zhang, Ph.D., Department of Cell Biology, LRI, Cleveland Clinic